Bayerische Motoren Werke ADR (BMWYY)

A newly published study shows that the fight against cancer could be boosted by considering approaches that seek to disrupt the mechanisms through which tumor cells respond to damage to their DNA. Targeting these pathways could make immunotherapy more effective for a lot more people.

BioMedWire Editorial Coverage : Chronic illnesses and rare disorders among older Americans represent a rapidly intensifying challenge for the U.S. healthcare system, with the National Institutes of Health estimating that more than 30 million people nationwide are living with a rare disease. Most of these conditions have no FDA-approved therapies, leaving older adults particularly at risk as age-related changes can mask or delay accurate diagnosis. This growing strain on care has heightened the need for novel treatments that address significant unmet medical needs. Soligenix Inc. (NASDAQ: SNGX) ( profile ), a late-stage biopharmaceutical developer, is advancing several rare-disease therapies, including HyBryte[TM] (synthetic hypericin) for cutaneous T-cell lymphoma (“CTCL”), where it is currently running the final confirmatory trial necessary before seeking global marketing authorization. As the Trump administration pursues new health-policy measures focused on chronic and rare diseases, Soligenix’s programs are positioned at a pivotal crossroads of scientific innovation and national healthcare goals. The company is working alongside several prominent leaders in the pharmaceutical and life sciences sectors, including AMGEN Inc. (NASDAQ: AMGN), Amicus Therapeutics Inc. (NASDAQ: FOLD), Citius Oncology Inc. (NASDAQ: CTOR) and…

The steep cost of healthcare in the U.S. has always been, and is becoming an even bigger political issue with each passing year. The issue was at the center of the recent shutdown of the federal government and the shutdown was only ended after a promise that the expiring healthcare subsidies would be voted on this month. Health insurance costs are soaring while citizens grapple with a high cost of living.

BioMedWire Editorial Coverage : Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the U.S. healthcare system, especially as more than 30 million Americans are affected by rare diseases, according to the National Institutes of Health. The vast majority of these conditions lack any FDA-approved treatment, leaving older adults especially vulnerable as age-related symptoms often obscure or delay diagnosis. This rising burden has increased demand for new therapies that can address real unmet need. Soligenix Inc. (NASDAQ: SNGX) ( Profile ), a late-stage biopharmaceutical company, is developing multiple treatments for rare diseases, including HyBryte[TM] (synthetic hypericin) for cutaneous T-cell lymphoma, and is now conducting the final confirmatory clinical study required before filing for worldwide marketing approval. As the Trump administration advances new health policy initiatives affecting chronic and rare diseases, Soligenix’s work sits at a critical intersection of medical innovation and national health priorities. The company is working alongside several leading companies committed to making an impact in the pharmaceutical and life sciences space, including Pfizer Inc. (NYSE: PFE), Merck & Co Inc. (NYSE: MRK), Bristol-Myers Squibb Co. (NYSE: BMY) and…

In a pivotal advancement for patients suffering from a rare form of skin cancer, Soligenix (NASDAQ: SNGX) has achieved a critical clinical trial milestone that brings its investigational treatment significantly closer to potential FDA approval. The company announced that is has completed the planned enrollment of 50 patients necessary for the interim analysis in its 80-patient confirmatory Phase 3 clinical trial evaluating HyBryte(TM) (synthetic hypericin) for the treatment of cutaneous T-cell lymphoma ( https://ibn.fm/ZeQoN ).

For a long time, the scientific community has known that anything that causes harm to the body usually also harms our brains. Conditions like insulin resistance, obesity and high blood pressure strain the body’s metabolic and vascular systems. With time, this stress accelerates cognitive decline and amplifies Alzheimer’s risk.

Chris Kendall, a renowned Geordie voiceover artist, has built a successful global career, working with top brands while staying connected to his North East roots.

Branded Legacy (OTC: BLEG), a provider of addiction treatment and harm-reduction solutions, reported third quarter revenue of just over $125,000 from its newly acquired Pau Hana subsidiary, a cash-flow-positive kava bar in West Melbourne, Florida. The company said Pau Hana’s strong daily retail performance provides a stable new revenue pillar and will serve as the blueprint for an aggressive 2026 expansion, including plans to open three to five new Florida locations and pursue additional acquisitions of profitable kava bars. Branded Legacy aims to build a scalable roll-up platform that layers centralized sourcing, branding and operational efficiencies across acquired venues, positioning the company to capitalize on rising demand for sober-social and functional beverage spaces.

Soligenix (NASDAQ: SNGX) is entering a new phase of strategic breadth and influence with the appointment of a seasoned, high-level scientific and policy adviser who brings rarefied experience at the intersection of economics, government and healthcare innovation. The company, a late-stage biopharmaceutical firm developing treatments for rare diseases, has announced the appointment of Tomas J. Philipson, PhD, as strategic advisor, a move that underscores Soligenix’s ambition to accelerate its lead programs and strengthen its regulatory, commercial and scientific positioning ( https://ibn.fm/T1EQ2 ).

Researchers studying how a common drug, hydralazine, for blood pressure and preeclampsia works at the cellular level have identified the specific mechanism through which it works and their discovery has revealed that the medication that has been around for more than half a century could find new application as a way to slow down how aggressively glioblastoma grows.

SANTA ANA, CA – BEST-VIP Chauffeured Worldwide, a trusted name in luxury ground transportation since 1995, has launched a newly redesigned website - https://www.best-vip.com - highlighting its extended services across Orange County and its international reach through a growing network of affiliates.

In a key development that underscores the advancing clinical trajectory of its lead therapy, Soligenix (NASDAQ: SNGX) announced that the Data Monitoring Committee (“DMC”) overseeing its confirmatory Phase 3 FLASH2 trial of HyBryte(TM) has reported no safety concerns to date, affirming the therapy’s safety profile. Soligenix, a biopharmaceutical company focused on rare diseases and treatments with substantial unmet need, is developing HyBryte (synthetic hypericin) for early-stage cutaneous T-cell lymphoma (“CTCL”) and is now advancing toward critical milestones in 2026.

HealthLynked (OTCQB: HLYK) said it has entered a Capital Market Advisory Agreement with “NE Holdings LLC,” a Florida-based consulting firm focused on senior exchange readiness and capital markets strategy, to support the Company plan to uplist to Nasdaq in the first half of 2026. NE Holdings will lead corporate and financial readiness efforts, oversee audit and compliance planning, assist with capital structure optimization, coordinate introductions to investment banks and key market participants, and advise on governance as HealthLynked advances its Nasdaq listing roadmap and broader public-market expansion strategy.

BioMedWire Editorial Coverage : As advanced biotech programs move closer to commercialization, fair-value adjustments under U.S. Generally Accepted Accounting Principles (“GAAP”) are increasingly recognized as meaningful signals of real scientific and business advancement. These valuations help translate research achievements into quantifiable economic impact, giving investors clearer insight into how innovation converts into company value. Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( profile ) this trend as it prepares for a major fair-value update on its 45% ownership in joint venture (“JV”) partner GMP Bio, following a new independent assessment that points to a substantial increase in the asset’s worth. This development further reinforces Oncotelic Therapeutics’ position as a treatment leader, along with others in the oncology-treatment space, including Iovance Biotherapeutics Inc . (NASDAQ: IOVA), Merck & Co. Inc. (NYSE: MRK), Eli Lilly and Company (NYSE: LLY) and…

The Smarter Way to Begin or End Your Heathrow Trip London, UK, 22nd November 2025, ZEX PR WIRE, Anyone who’s flown through Heathrow knows the routine — long flights, queues at customs, juggling luggage and connections. It’s precisely at this point that Sky Bridge Cars steps in, turning what could be

Los Angeles, CA - Nizo Luxury (ph: 424-303-6496), Beverly Hills’ rapidly growing premium car rental and vehicle management company, announces an expanded service lineup and the opening of its new flagship location on Robertson Blvd. The move marks a major step in the company’s mission to become the most trusted, service-driven premium rental provider in Los Angeles.

Oncotelic Therapeutics (OTCQB: OTLC) was highlighted in a BioMedWire editorial examining how fair-value remeasurements under GAAP are becoming key indicators of real scientific and commercial progress in late-stage biotech pipelines. The piece notes that Oncotelic is preparing for a significant fair-value remeasurement of its 45% stake in JV entity GMP Bio following a new independent valuation suggesting a potential step-up in asset value, reinforcing the company’s position as it advances its oncology efforts.

It may sound strange to speak of exercising and cancer treatment in the same breath, but experts and numerous studies have documented the immense value that patients can attain by integrating exercise into their schedule during the duration that they are receiving treatment for cancer. We address some of the queries that cancer patients may have about exercising during their treatment.

Scorpion Locksmith Houston has announced an expanded focus on professional car key replacement services for drivers throughout the Houston area. The company aims to provide faster response times and dependable solutions for those facing the inconvenience of lost, broken, or malfunctioning keys. As part of this service update, customers can easily access car key support through https://scorpionlocksmithhouston.com/car-keys-replacement/ for quick information and assistance.

On Tuesday, Senator Bernie Sanders authored a letter that he sent to Democrats in both chambers of Congress urging them to band together and support the Affordable Care Act. He wrote that a lot more can be done to improve healthcare in the country and made six suggestions that can help in attaining this objective.

BioMedWire Editorial Coverage : As late-stage biotech pipelines mature, fair-value remeasurements under U.S. Generally Accepted Accounting Principles (“GAAP”) are emerging as critical indicators of tangible scientific and commercial progress. These revaluations provide a financial bridge between laboratory breakthroughs and shareholder value, offering investors a clearer picture of how innovation becomes measurable enterprise worth. Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( profile ) exemplifies this shift as the company prepares for a significant fair-value remeasurement of its 45% stake in joint venture (“JV”) entity GMP Bio, driven by a new independent valuation indicating a potential step-up in asset value. This key shift strengthens Oncotelic Therapeutics position in the oncology space as the company works to make a difference, along with other innovative leaders such as IO Biotech Inc. (NASDAQ: IOBT), Novartis AG (NYSE: NVS), Bicara Therapeutics Inc. (NASDAQ: BCAX) and…

That sinking feeling hits hard. Keys gone. Maybe they're on the kitchen counter back home. Maybe they're in an Uber headed toward Concord. Or worse, they're locked inside the car, visible through the window in a Walnut Creek parking lot. It's a uniquely frustrating moment that Lockology Locksmith has built an entire business around solving.

Lockology Locksmith is a family-owned mobile locksmith service that serves Oakland and the East Bay Area with over 15 years of experience.

North Vancouver, BC - Bruno Automotive, one of North Vancouver’s most trusted and longest-standing auto repair facilities, proudly announces its continued expansion and commitment to transparent, high-level automotive care. Since opening its doors in 1983, the family-built shop has become the go-to destination for drivers seeking reliability, expert craftsmanship, and a customer-first experience—backed by a reputation that spans over four decades.

For a while, the media has been filled with claims that vaccines cause autism . These claims have been amplified by public figures like the U.S. Secretary of Health & Human Services, R. F. Kennedy Jr., as well as other public health leaders. Now a parent, Greg Scaduto, whose child is autistic, has come out to explain why such thinking is misguided and does more harm than good.